Brinker Capital Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $789K | Sell |
1,504
-326
| -18% | -$171K | 0.01% | 1318 |
|
|
2025
Q1 | $1.16M | Sell |
1,830
-252
| -12% | -$160K | 0.01% | 1002 |
|
|
2024
Q4 | $1.48M | Sell |
2,082
-489
| -19% | -$348K | 0.01% | 842 |
|
|
2024
Q3 | $2.7M | Sell |
2,571
-302
| -11% | -$317K | 0.03% | 542 |
|
|
2024
Q2 | $3.02M | Buy |
2,873
+138
| +5% | +$145K | 0.03% | 473 |
|
|
2024
Q1 | $2.63M | Sell |
2,735
-36
| -1% | -$34.6K | 0.03% | 528 |
|
|
2023
Q4 | $2.5M | Sell |
2,771
-12,934
| -82% | -$11.7M | 0.03% | 534 |
|
|
2023
Q3 | $12.9M | Sell |
15,705
-1,109
| -7% | -$913K | 0.16% | 138 |
|
|
2023
Q2 | $12.1M | Sell |
16,814
-458
| -3% | -$329K | 0.13% | 153 |
|
|
2023
Q1 | $14.2M | Buy |
17,272
+1,395
| +9% | +$1.15M | 0.18% | 122 |
|
|
2022
Q4 | $11.5M | Sell |
15,877
-4,121
| -21% | -$2.97M | 0.23% | 100 |
|
|
2022
Q3 | $13.8M | Sell |
19,998
-484
| -2% | -$333K | 0.28% | 82 |
|
|
2022
Q2 | $12.1M | Sell |
20,482
-179
| -0.9% | -$106K | 0.23% | 96 |
|
|
2022
Q1 | $14.4M | Sell |
20,661
-5,492
| -21% | -$3.84M | 0.22% | 101 |
|
|
2021
Q4 | $16.5M | Sell |
26,153
-8,011
| -23% | -$5.06M | 0.24% | 84 |
|
|
2021
Q3 | $19.1M | Buy |
34,164
+768
| +2% | +$430K | 0.3% | 74 |
|
|
2021
Q2 | $18.7M | Buy |
33,396
+5,741
| +21% | +$3.21M | 0.25% | 98 |
|
|
2021
Q1 | $13.1M | Buy |
+27,655
| New | +$13.1M | 0.2% | 126 |
|
|
2020
Q4 | – | Sell |
-13,676
| Closed | -$7.66M | – | 1162 |
|
|
2020
Q3 | $7.66M | Buy |
+13,676
| New | +$7.66M | 0.13% | 177 |
|
|
2020
Q1 | – | Sell |
-3
| Closed | -$1K | – | 654 |
|
|
2019
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 782 |
|